Technology | March 14, 2011

Vascular Graft Receives CE Mark

March 14, 2011 – A vascular graft for hemodialysis access has received the CE mark. The Gore Propaten vascular graft, from W.L. Gore and Associates, utilizes a covalent bonding technology to adhere heparin to the graft surface.

Arteriovenous (AV) grafts are used to create a conduit for repeated blood access during hemodialysis, allowing blood to be withdrawn from the body and cleansed when a patient has end stage renal disease (ESRD), commonly referred to as kidney failure. During the implantation procedure, a vascular graft is implanted through two small incisions in the arm. Once a tunnel is created under the skin, one end of the vascular graft is sewn to the artery and the other to the vein. Blood can then flow rapidly from the artery through the vascular graft into the vein, producing the higher flow rates needed for the hemodialysis process.

The Carmeda BioActive Surface (CBAS) activity has demonstrated long-lasting effectiveness in a clinical explant of up to three years after implantation. It allows blood flowing through the graft to resist thrombosis or clotting. The graft is composed of an expanded polytetrafluoroethylene (ePTFE) material with excellent handling properties and flexibility for ease of use.

The device has been used in lower extremity applications in the United States since 2006 and in Europe for more than 10 years, with a reported one-year primary patency in below-knee bypasses of 80 percent, compared with 66 percent for standard ePTFE and 81 percent for autologous vein bypasses. With more than 18,000 dialysis access implants worldwide, it is the only vascular graft of its kind on the market approved for hemodialysis access. Interim results of a prospective, nonrandomized study comparing it to a non heparin-bonded graft in high-risk patients for hemodialysis access application found that the Gore Propaten vascular grafts have a significant improvement of 20 percent in clot-free survival compared to the control group.

“This is forward progress in adding a new bioactive technology to address the graft failure mode of thrombosis. The Gore Propaten vascular graft has been successfully demonstrated in the lower extremities, and it is an exciting new option for hemodialysis use,” said Eric Chemla, M.D., consultant renal transplant and vascular surgeon, St. George’s Healthcare U.K. National Health Service (NHS) Trust.

The graft is now available in multiple configurations, including 4 – 7 mm tapers and integrated rings. The cross-sectional profile is reduced by approximately 24 percent when compared to an externally ringed vascular graft.

For more information: www.goremedical.com

Related Content

Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...
Society of Interventional Radiology Announces 2019 Gold Medalists
News | Interventional Radiology | April 08, 2019
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Alan H. Matsumoto, M....
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Interventional Radiology Treatment for Tennis Elbow Reduces Pain and Inflammation

Image courtesy of Yuji Okuno

News | Interventional Radiology | March 29, 2019
Tennis elbow, a painful chronic condition that affects up to 3 percent of U.S. adults, can be effectively treated...
New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019
Training interventional radiologists to perform endovascular thrombectomies results in positive outcomes for patients...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...

Photo courtesy of Philips Healthcare

Feature | Interventional Radiology | February 27, 2019 | By Lavi Nissim, M.D.
Picture, for a moment, the following: You are making acquaintance with someone new who is not in the medical professi